William Blair analyst Ryan Daniels has maintained their bullish stance on TMDX stock, giving a Buy rating today.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ryan Daniels’s rating is based on a combination of factors that indicate a positive outlook for TransMedics Group. The company has experienced a rebound in its flight data at the start of the fourth quarter, suggesting a recovery from the seasonal decline observed in the third quarter. This recovery is evidenced by an increase in the average number of daily flights, which has risen to 25.7 in October, surpassing the third quarter’s average of 22.8 flights per day.
Furthermore, the upward trend in flight volumes throughout October is a promising sign for the company’s operational performance. The consistent increase in weekly flight volumes suggests a strengthening demand for TransMedics’ services, which is a positive indicator for future growth. These factors contribute to Ryan Daniels’s confidence in the company’s potential, leading to a Buy rating for TransMedics Group’s stock.
In another report released today, Needham also upgraded the stock to a Buy with a $148.00 price target.
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is neutral on the stock.